Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing Trial.
Gotti E, Perico N, Gaspari F, Cattaneo D, Lesti MD, Ruggenenti P, Segoloni G, Salvadori M, Rigotti P, Valente U, Donati D, Sandrini S, Federico S, Sparacino V, Mourad G, Bosmans JL, Dimitrov BD, Iordache BE, Remuzzi G. Gotti E, et al. Among authors: segoloni g. Transplant Proc. 2005 Jun;37(5):2037-40. doi: 10.1016/j.transproceed.2005.03.096. Transplant Proc. 2005. PMID: 15964332 Clinical Trial.
A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine.
Montagnino G, Sandrini S, Casciani C, Schena FP, Carmellini M, Civati G, Rigotti P, Cossu M, Altieri P, Salvadori M, Federico S, Stefoni S, Cambi V, Albertazzi A, Buoncristiani U, Berloco P, Segoloni G, Boschiero L, Sparacino V, Donati D, Turello E, Dal Canton A, Ponticelli C. Montagnino G, et al. Among authors: segoloni g. Transplant Proc. 2005 Mar;37(2):788-90. doi: 10.1016/j.transproceed.2004.11.033. Transplant Proc. 2005. PMID: 15848532 Clinical Trial.
ABCB1 genotypes predict cyclosporine-related adverse events and kidney allograft outcome.
Cattaneo D, Ruggenenti P, Baldelli S, Motterlini N, Gotti E, Sandrini S, Salvadori M, Segoloni G, Rigotti P, Donati D, Perico N, Remuzzi G; Mycophenolate Steroids Sparing (MYSS) Genetics Study Group. Cattaneo D, et al. Among authors: segoloni g. J Am Soc Nephrol. 2009 Jun;20(6):1404-15. doi: 10.1681/ASN.2008080819. Epub 2009 May 21. J Am Soc Nephrol. 2009. PMID: 19470683 Free PMC article.
Study of lymphocyte costimulatory molecules in renal transplantation.
Biancone L, Donati D, Segoloni G, Turello E, Squiccimarro G, Bussolati B, Cantaluppi V, Amann F, Gastaldi L, Piccoli G, Camussi G. Biancone L, et al. Among authors: segoloni g. Transplant Proc. 1998 Aug;30(5):2384-6. doi: 10.1016/s0041-1345(98)00662-9. Transplant Proc. 1998. PMID: 9723512 No abstract available.
Basiliximab significantly reduces acute rejection in renal transplant patients given triple therapy with azathioprine.
Ponticelli C, Yussim A, Cambi V, Legendre C, Rizzo G, Salvadori M, Kahn D, Kashi SH, Salmela K, Fricke L, Garcia-Martinez J, Lechler R, Heemann U, Monteon F, Ortuño J, Amenabar JJ, Arias M, Nicholson ML, Sperschneider H, Abendroth D, Gracida C, Lao M, Sever MS, Lameire N, Sanchez-Fructuoso A, Bascì A, Segoloni G, Connolly J, Altieri P, Akoh J, Prestele H, Girault D. Ponticelli C, et al. Among authors: segoloni g. Transplant Proc. 2001 Feb-Mar;33(1-2):1009-10. doi: 10.1016/s0041-1345(00)02307-1. Transplant Proc. 2001. PMID: 11267167 Clinical Trial. No abstract available.
Comparison between a two-drug regimen with tacrolimus and steroids and a triple one with azathioprine in kidney transplantation: results of a European trial with 3-year follow up.
Pascual J, Segoloni G, Gonzalez Molina M, del Castillo D, Capdevila L, Arias M, Garcia J, Ortuño J; Spanish-Italian Tacrolimus Study Group. Pascual J, et al. Among authors: segoloni g. Transplant Proc. 2003 Aug;35(5):1701-3. doi: 10.1016/s0041-1345(03)00608-0. Transplant Proc. 2003. PMID: 12962764 Clinical Trial.
366 results